The role of vascular endothelial growth factor in ossification

International Journal of Oral Science

Volumn 4, Issue 2, 2012, Pages 64-68

  Yang, Yan Qi ^a   Tan, Ying Ying ^a,b   Wong, Ricky ^a   Wenden, Alex ^a   Zhang, Lin Kun ^a,c   Rabie, A Bakr M ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Poliklinik Komuniti Mak Mandin   (Malaysia)

^c NANKAI UNIVERSITY   (China)

Author keywords

endochondral ossification; intramembranous ossification; osteogenesis; vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; BONE; BONE DEVELOPMENT; BONE MINERALIZATION; BONE REMODELING; CARTILAGE; CYTOLOGY; HUMAN; OSTEOCLAST; PHYSIOLOGY; REVIEW;

ANIMALS; BONE AND BONES; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; CARTILAGE; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOCLASTS; OSTEOGENESIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864260041     PISSN: 16742818     EISSN: 20493169     Source Type: Journal    
DOI: 10.1038/ijos.2012.33     Document Type: Review

References (52)

1. Marks SC, Hermey DC. The structure and development of bone. In: Bilezekian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. San Diego: Academic Press; 1996: 3-24.
2. Kanczler JM, Oreffo RO. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 2008; 2(15): 100-114. (Pubitemid 351955734)
3. Mandracchia VJ, Nelson SC, Barp EA. Current concepts of bone healing. Clin Podiatr Med Surg 2001; 18(1): 55-77. (Pubitemid 32381942)
4. Rabie AB. Vascular endothelial growth pattern during demineralized bone matrix induced osteogenesis. Connect Tissue Res 1997; 36(4): 337-345. (Pubitemid 28214041)
5. Carmeliet P, Ferreira V, Breier G et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380(6573): 435-439. (Pubitemid 26102719)
6. Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380(6573): 439-443.
7. Gerber HP, Hillan KJ, Ryan AM et al. VEGF is required for growth and survival in neonatal mice. Development 1999; 126(6): 1149-1159. (Pubitemid 29182112)
8. Emad B, Sherif EM, Basma GM et al. Vascular endothelial growth factor augments the healing of demineralized bone matrix grafts. Int J Surg 2006; 4(3): 160-166. (Pubitemid 44462759)
9. Dai J, Rabie AB. Direct AAV-mediated gene delivery to the temporomandibular joint. Front Biosci 2007; 12: 2212-2220.
10. Dai J, Rabie AB. Recombinant adeno-associated virus vector hybrids efficiently target different skeletal cells. Front Biosci 2007; 12: 4280-4287.
11. Rabie ABM, Dai J, Xu R. Recombinant AAV-mediated VEGF gene therapy induces mandibular condylar growth. Gene Ther 2007; 14(12): 972-980. (Pubitemid 46865508)
12. Li R, Stewart DJ, von Schroeder HP et al. Effect of cell-based VEGF gene therapy on healing of a segmental bone defect. J Orthop Res 2009; 27(1):8-14.
13. Ferrara N, Davis Symth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18(1): 4-25. (Pubitemid 27076453)
14. Roy H, Bhardwaj S, Ylä-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006; 580(12): 2879-2887. (Pubitemid 43729175)
15. Thomas KA. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996; 271(2): 603-606. (Pubitemid 26034900)
16. Ferrara N, Gerber, HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9(6): 669-676. (Pubitemid 36749215)
17. Pouyssegur J, Dayan F, Mazure NM. Hypoxia signaling in cancer and approaches to enforce tumour regression. Nature 2006; 441(7092): 437-443. (Pubitemid 44050138)
18. Chan D, Suthphin P, Denko N et al. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J Biol Chem 2002; 277(42): 40112-40117. (Pubitemid 35191002)
19. Fukuda R, Hirota K, Fan F et al. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 2002; 277(41): 38205-38211. (Pubitemid 35154674)
20. Laughner E, Taghavi P, Chiles K et al. HER2 (neu) signaling increases the rate of hypoxiainducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001; 21(12): 3995-4004. (Pubitemid 32476461)
21. Wang Y, Wan C, Deng L et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 2007; 117(6): 1616-1626. (Pubitemid 46871346)
22. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25(4): 581-611. (Pubitemid 39099316)
23. Waltenberger J, Claesson-Welsh L, Siegbahn A et al. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994; 269(43): 26988-26995. (Pubitemid 24332901)
24. Soker S, Takashima S, Miao HQ et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92(6): 735-745. (Pubitemid 28155313)
25. Mayr-Wohlfart U, Waltenberger J, Hausser H et al. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 2002; 30(3): 472-477. (Pubitemid 34204121)
26. Fiedler J, Leucht F, Waltenberger J et al. VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 2005; 334(2): 561-568. (Pubitemid 40982403)
27. Street J, Bao M, deGuzman L et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002; 99(15): 9656-9661. (Pubitemid 34831103)
28. Deckers MM, Karperien M, van der Bent C et al. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 2000; 141(5): 1667-1674. (Pubitemid 32274395)
29. Katagiri T, Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 2002; 8(3): 147-159. (Pubitemid 34535063)
30. Yasuda H, Shima N, Nakagawa N et al. A novel molecular mechanism modulating osteoclast differentiation and function. Bone 1999; 25(1): 109-113. (Pubitemid 29322072)
31. Min JK, Kim YM, Kim YM et al. Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand. J Biol Chem 2003; 278(41): 39548-39557.
32. Yao S, Liu D, Pan F et al. Effect of vascular endothelial growth factor on RANK gene expression in osteoclast precursors and on osteoclastogenesis. Arch Oral Biol 2006; 51(7): 596-602. (Pubitemid 43849636)
33. Nakagawa M, Kaneda T, Arakawa T et al. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 2000; 473(2): 161-164. (Pubitemid 30254282)
34. Rabie AB, Hä gg U. Factors regulating mandibular condylar growth. Am J Orthod Dentofacial Orthop 2002; 122(4): 401-409. (Pubitemid 40432960)
35. Rabie AB, Leung FY, Chayanupatkul A et al. The correlation between neovascularization and bone formation in the condyle during forward mandibular positioning. Angle Orthod 2002; 72(5): 431-443.
36. Rabie AB, Shum L, Chayanupatkul A. VEGF and bone formation in the glenoid fossa during forward mandibular positioning. Am J Orthod Dentofacial Orthop 2002; 122(2): 202-209. (Pubitemid 40432997)
37. Bluteau G, Julien M, Magne D et al. VEGF and VEGF receptors are differentially expressed in chondrocytes. Bone 2007; 40(3): 568-576. (Pubitemid 46201943)
38. Zelzer E, Mamluk R, Ferrara N et al. VEGFA is necessary for chondrocyte survival during bone development. Development 2004; 131(9): 2161-2171. (Pubitemid 38702047)
39. Xiong H, Rabie AB, Hagg U. Neovascularization and mandibular condylar bone remodelling in adult rats under mechanical strain. Front Biosci 2005; 10: 74-82. (Pubitemid 40543019)
40. Dai J, Rabie ABM. VEGF: an essential mediator of both angiogenesis and endochondral ossification. J Dent Res 2007; 86(10): 937-950.
41. Cortina-Ramírez GE, Chimal-Monroy J. Differential effects of vascular endothelial growth factor on joint formation during limb development. Ann N Y Acad Sci 2007; 1116: 134-140.
42. Bjork A. Cranial base development. Am J Orthod 1955; 41(3): 198-225.
43. Lei WY, Wong RW, Rabie AB. Factors regulating endochondral ossification in the spheno-occipital synchondrosis. Angle Orthod 2008; 78(2): 215-220.
44. Gerber HP, Vu TH, Ryan AM et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5(6): 623-628. (Pubitemid 29289424)
45. Geiger F, Bertram H, Berger I et al. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 2005; 20(11): 2028-2035. (Pubitemid 41532788)
46. Peng H, Wright V, Usas A et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 2002; 110(6): 751-759.
47. Rabie AB, Zhao Z, Shen G et al. Osteogenesis in the glenoid fossa in response to mandibular advancement. Am J Orthod Dentofacial Orthop 2001; 119(4): 390-400. (Pubitemid 33608777)
48. Shum L, Rabie AB, Hägg U. Vascular endothelial growth factor expression and bone formation in posterior glenoid fossa during stepwise mandibular advancement. Am J Orthod Dentofacial Orthop 2004; 125(2): 185-190. (Pubitemid 38199815)
49. Tatsuyama K, Maezawa Y, Baba H et al. Expression of various growth factors for cell proliferation and cytodifferentiation during fracture repair of bone. Eur J Histochem 2000; 44(3): 269-278.
50. Codivilla A. On the means of lengthening, in the lower limbs, the muscles and tissues which are shortened through deformity. Am J Orthop Surg 1905; 2: 353-369.
51. Lewinson D, Maor G, Rozen N et al. Expression of vascular antigens by bone cells during bone regeneration in a membranous bone distraction system. Histochem Cell Biol 2001; 116(5): 381-388. (Pubitemid 33141270)
52. Jacobsen KA, Al-Aql ZS, Wan C et al. Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling. J Bone Miner Res 2008; 23(5): 596-609. (Pubitemid 351575014)